Showing results (351-360 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|October 1, 1995
Apoptosis and c-jun induction by cisplatin in a human melanoma cell line and a drug-resistant daughter cell lineR Zhao, Y B Rabo, S Egyházi, et al.
Anti-Cancer Drugs|October 1, 1995
Evaluation of certain ureas and nitrosoureas of 2,3-dihydro-1,4-benzothiazines against Sarcoma-180 solid tumors in vivoM K Nyati, C M Rajoria, R R Gupta, et al.
Anti-Cancer Drugs|December 1, 1995
Alpha-tocopherol ameliorates cyclophosphamide-induced hyperlipidemia in fibrosarcoma-bearing ratsS Ilanchezhian, M Thangaraju, S Sasirekha, et al.
Anti-Cancer Drugs|October 1, 1995
The importance of dose and schedule in cancer chemotherapy: epithelial ovarian cancerP N Mainwaring, M E Gore
Anti-Cancer Drugs|October 1, 1995
Experience with dose and schedule variations in germ cell tumorsP H De Mulder, R de Wit
Anti-Cancer Drugs|October 1, 1995
The problem of thrombocytopenia and its managementA C Newland
Anti-Cancer Drugs|February 1, 1997
Treatment of advanced seminoma: an updateD T Sleijfer, N H Mulder
Anti-Cancer Drugs|February 1, 1997
Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitroU A Germann, D Shlyakhter, V S Mason, et al.
Anti-Cancer Drugs|February 1, 1997
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatinU Masanek, G Stammler, M Volm
Anti-Cancer Drugs|February 1, 1997
Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cellsT Asakura, N Takahashi, K Takada, et al.
Pageof 464